Literature DB >> 33627793

Pathological correlates and predictive biomarkers for neoadjuvant ICIs in melanoma.

David Killock1.   

Abstract

Entities:  

Year:  2021        PMID: 33627793     DOI: 10.1038/s41571-021-00488-y

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

Authors:  Alexander M Menzies; Rodabe N Amaria; Elisa A Rozeman; Alexander C Huang; Michael T Tetzlaff; Bart A van de Wiel; Serigne Lo; Ahmad A Tarhini; Elizabeth M Burton; Thomas E Pennington; Robyn P M Saw; Xiaowei Xu; Giorgos C Karakousis; Paolo A Ascierto; Andrew J Spillane; Alexander C J van Akkooi; Michael A Davies; Tara C Mitchell; Hussein A Tawbi; Richard A Scolyer; Jennifer A Wargo; Christian U Blank; Georgina V Long
Journal:  Nat Med       Date:  2021-02-08       Impact factor: 53.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.